Literature DB >> 15581067

A Gly482Ser polymorphism of the peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) gene is associated with type 2 diabetes in Caucasians.

T Kunej1, M Globocnik Petrovic, P Dovc, B Peterlin, D Petrovic.   

Abstract

The PGC-1 gene has been implicated in the regulation of several genes controlling energy metabolism. The prevalent Gly482Ser polymorphism of the PGC-1 gene has been shown to be associated with type 2 diabetes in some but not all studies. The aim of this study was to analyse whether the Gly482Ser variant is a risk factor for development of type 2 diabetes in Slovene population (Caucasians). Genotyping of the Gly482Ser polymorphism was performed for 545 subjects: 305 patients with type 2 diabetes and 240 non-diabetic controls. The Gly482Ser genotype distribution in patients with type 2 diabetes (AA = 11.5%, AG = 42.3%, GG = 46.2%) differed from genotype distribution in non-diabetic controls (AA = 6.3%, AG = 46.3%, GG = 47.5%), and the AA genotype was associated with 1.9-times increased risk of type 2 diabetes (95% confidence interval 1.0-3.6; P = 0.036). In conclusion, we suggest that the AA genotype of the Gly482Ser polymorphism of the PGC-1 gene should be considered as a risk factor for the development of type 2 diabetes in Caucasians.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15581067

Source DB:  PubMed          Journal:  Folia Biol (Praha)        ISSN: 0015-5500            Impact factor:   0.906


  20 in total

1.  Genetic Variants in the Activation of the Brown-Like Adipocyte Pathway and the Risk for Severe Obesity.

Authors:  Ana Carolina Proença da Fonseca; Guilherme Proença da Fonseca; Bruna Marchesini; Danielle Dutra Voigt; Mario Campos Junior; Verônica Marques Zembrzuski; João Regis Ivar Carneiro; José Firmino Nogueira Neto; Pedro Hernan Cabello; Giselda Maria Kalil Cabello
Journal:  Obes Facts       Date:  2020-04-23       Impact factor: 3.942

2.  Association between the PPARa and PPARGCA gene variations and physical performance in non-trained male adolescents.

Authors:  Farzad Zehsaz; Hamed Abbasi Soltani; Roya Hazrati; Negin Farhangi; Amir Monfaredan; Mehri Ghahramani
Journal:  Mol Biol Rep       Date:  2018-10-15       Impact factor: 2.316

3.  Association of PGC-1α gene with type 2 diabetes in three unrelated endogamous groups of North-West India (Punjab): a case-control and meta-analysis study.

Authors:  Rubina Sharma; Kawaljit Matharoo; Rohit Kapoor; A J S Bhanwer
Journal:  Mol Genet Genomics       Date:  2017-10-24       Impact factor: 3.291

4.  HTR1B, ADIPOR1, PPARGC1A, and CYP19A1 and obesity in a cohort of Caucasians and African Americans: an evaluation of gene-environment interactions and candidate genes.

Authors:  Todd L Edwards; Digna R Velez Edwards; Raquel Villegas; Sarah S Cohen; Maciej S Buchowski; Jay H Fowke; David Schlundt; Jirong Long; Ji Rong Long; Qiuyin Cai; Wei Zheng; Xiao-Ou Shu; Margaret K Hargreaves; Jeffrey Smith; Smith Jeffrey; Scott M Williams; Lisa B Signorello; William J Blot; Charles E Matthews
Journal:  Am J Epidemiol       Date:  2011-11-20       Impact factor: 4.897

5.  Effect of Peroxisome Proliferator-Activated Receptor-γ Coactivator-1 Alpha Variants on Spontaneous Clearance and Fibrosis Progression during Hepatitis C Virus Infection in Moroccan Patients.

Authors:  Raouia ElFihry; Mohcine Elmessaoudi-Idrissi; Fatima-Zahra Jadid; Imane Zaidane; Hajar Chihab; Mohamed Tahiri; Mostafa Kabine; Wafaa Badre; Isabelle Chemin; Agnes Marchio; Pascal Pineau; Sayeh Ezzikouri; Soumaya Benjelloun
Journal:  Virol Sin       Date:  2020-04-15       Impact factor: 4.327

6.  Peroxisome proliferator-activated receptor gamma co-activator 1 gene Gly482Ser polymorphism is associated with the response of low-density lipoprotein cholesterol concentrations to exercise training in elderly Japanese.

Authors:  Takuro Tobina; Yukari Mori; Yukiko Doi; Fuki Nakayama; Akira Kiyonaga; Hiroaki Tanaka
Journal:  J Physiol Sci       Date:  2016-10-03       Impact factor: 2.781

Review 7.  PPAR transcriptional activator complex polymorphisms and the promise of individualized therapy for heart failure.

Authors:  Neville F Mistry; Sharon Cresci
Journal:  Heart Fail Rev       Date:  2008-11-08       Impact factor: 4.214

8.  PPARGC1A variation associated with DNA damage, diabetes, and cardiovascular diseases: the Boston Puerto Rican Health Study.

Authors:  Chao-Qiang Lai; Katherine L Tucker; Laurence D Parnell; Xian Adiconis; Bibiana García-Bailo; John Griffith; Mohsen Meydani; José M Ordovás
Journal:  Diabetes       Date:  2007-12-27       Impact factor: 9.461

Review 9.  PGC-1 coactivators: inducible regulators of energy metabolism in health and disease.

Authors:  Brian N Finck; Daniel P Kelly
Journal:  J Clin Invest       Date:  2006-03       Impact factor: 14.808

10.  THE PPARGC1A - GLY482SER POLYMORPHISM (RS8192678) AND THE METABOLIC SYNDROME IN A CENTRAL ROMANIAN POPULATION.

Authors:  K Csép; E Szigeti; M Vitai; L Korányi
Journal:  Acta Endocrinol (Buchar)       Date:  2017 Apr-Jun       Impact factor: 0.877

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.